Drivers and strategies to combat substandard and falsified medicines in low-and middle-income countries: A systematic review of qualitative evidence

MHRA and eBay working in partnership to safeguard public health

A patient safety escape room simulation for internal medicine learners, based on hazards identified in local incident reports

Regional Trends in the Opioid Epidemic Using Safety Signals of Drug Abuse and Dependence: A Disproportionality Analysis Using VigiBase

Artificial Intelligence in Personalized Breast Cancer Drug Safety: From Preclinical Toxicology to Clinical Risk Management

Counterfeiters cash in on the world’s bestselling cancer drug

CEPI and PAHO expand partnership to strengthen regulatory systems and vaccine safety across the Americas

AI-Driven Cybersecurity Architectures for Pharmaceutical Manufacturing and Supply Chains

Association study of aromatase inhibitors and adverse events related to osteoporosis: based on pharmacovigilance data

Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system

Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase

Deep Learning Approaches to ADMET Prediction: Improving Drug Safety and Pharmacokinetics

“Making One's Own Doctor”:“Épicerie medicine” and the Informal Circulation of Antibiotics in Northern Madagascar

Drug resistant fungi warning

Efficacy and Safety of Intrathecal Buprenorphine for Postoperative Analgesia in Cesarean Delivery: A Systematic Review of Randomized Controlled Trials

Pharmacovigilance analysis of vaccination errors during pregnancy using VAERS data

Decoding adverse event signals of folic acid supplementation in cardiac patients: a stratified pharmacovigilance analysis based on FAERS

Adverse Drug Reaction Detection on Social Media Based on Large Language Models

A hierarchical risk assessment framework for head-to-head comparison of statin safety profiles in Chinese patients

Thalidomide memorial activity: pedagogies of creativity, joy and immersion in medical education

Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome

Boletín sobre Medicamentos Veterinarios. Enero-Marzo 2026

Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing

Clínic Barcelona reaches over 1,000 adverse drug reaction reports through a pioneering pharmacovigilance programme

Hyaluronic Acid Products Containing Undeclared Ingredients

Changes in Mifepristone Use at Pharmacies After Removal of the FDA In-Person Dispensing Requirement

Can Genes Affect GLP-1 Side Effects and Treatment Outcomes?

Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer

Updated EMA-HMA workplan on data and AI in medicines regulation 2026 to 2028

Sexual Safety Signals of Common Antidiabetic Drugs: Insights From FAERS Disproportionality Analysis

US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008–2022)

Real-World Safety Signals of Drug-Induced Proteinuria: A Two-Decade Pharmacovigilance Study Using Multi-Indicator Detection and Multivariate Correction

Gastrointestinal adverse events associated with tirzepatide: A bibliometric and pharmacovigilance analysis

Safety profile and signal detection of tadalafil: a real-world analysis based on the Food and Drug adverse event reporting system

Assessing Research Impact With Bibliometrics and Altmetrics: The Case of the Canadian Network for Observational Drug Effect Studies (CNODES)

Safety and Effectiveness of Contezolid versus Linezolid in Drug-Resistant Tuberculosis: A 12-Month Retrospective Study from China

Performance-enhancing drug use in sports: a Bayesian variable selection and profile regression approach to identifying risk factors and estimating prevalence